Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1971 1
1973 1
1974 1
1976 1
1978 3
1979 2
1981 2
1982 2
1983 1
1984 1
1985 2
1986 1
1987 4
1988 6
1989 6
1990 5
1991 7
1992 13
1993 2
1994 5
1995 6
1996 6
1997 13
1998 5
1999 6
2000 12
2001 7
2002 7
2003 6
2004 3
2005 4
2006 9
2007 5
2008 2
2009 4
2010 1
2011 6
2012 2
2013 2
2014 3
2015 3
2016 3
2017 9
2018 10
2019 12
2020 5
2021 4
2022 3
2023 11
2024 11
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. doi: 10.1182/blood-2012-02-410746. Epub 2012 Jun 19. Blood. 2012. PMID: 22715121 Free article. Clinical Trial.
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Pfreundschuh M, Kuhnt E, Trümper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N; MabThera International Trial (MInT) Group. Pfreundschuh M, et al. Lancet Oncol. 2011 Oct;12(11):1013-22. doi: 10.1016/S1470-2045(11)70235-2. Epub 2011 Sep 21. Lancet Oncol. 2011. PMID: 21940214 Clinical Trial.
Naproxen nephrotoxicity.
Cartwright KC, Trotter TL, Cohen ML. Cartwright KC, et al. Ariz Med. 1979 Feb;36(2):124-6. Ariz Med. 1979. PMID: 420591 No abstract available.
Diagnostic criteria and core outcome set development for necrotising otitis externa: the COSNOE Delphi consensus study.
Lodhi S, Dodgson K, Dykes M, Vishwanath V, Bazaz R, Mathur S, Watson G, Cartwright K, Pearson A, Wearmouth D, List R, Yates P, Dixon J, Puveendran A, Wilson M, Watson K, Cullinan M, Mentias Y, Capper R, Jewes L, Wallis S, Hamilton D, Adams B, Khalid-Raja M, Faris B, Khan M, Linton S, Abrar R, Owen E, Bisbinas V, Ijaz A, Lau K, Timms S, Bruce J, Stapleton E. Lodhi S, et al. Among authors: cartwright k. J Laryngol Otol. 2024 Sep;138(9):913-920. doi: 10.1017/S0022215124000513. Epub 2024 Apr 22. J Laryngol Otol. 2024. PMID: 38644734 Free PMC article.
Meningococcal meningitis.
Cartwright KA. Cartwright KA. Br J Hosp Med. 1987 Dec;38(6):516, 521-4. Br J Hosp Med. 1987. PMID: 3325120 Review.
Chemoprophylaxis for Haemophilus influenzae type b.
Cartwright KA, Begg NT, Hull D. Cartwright KA, et al. BMJ. 1991 Mar 9;302(6776):546-7. doi: 10.1136/bmj.302.6776.546. BMJ. 1991. PMID: 2021714 Free PMC article. No abstract available.
238 results